Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
New product line to address the challenge of restrictions on use of plastic straws
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
The company also plans to expand the facility
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Both companies have been selected for stand-by production by German government
Subscribe To Our Newsletter & Stay Updated